{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:20:42Z","timestamp":1790878842134,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004189","name":"Max Planck Society","doi-asserted-by":"publisher","award":["M.KF.A.BIOC0001-K440"],"award-info":[{"award-number":["M.KF.A.BIOC0001-K440"]}],"id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["NA400\/10-401246035"],"award-info":[{"award-number":["NA400\/10-401246035"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["NA400\/9"],"award-info":[{"award-number":["NA400\/9"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neo.2025.101196","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:07:07Z","timestamp":1751382427000},"page":"101196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The immune response against cancer is modulated by stromal cell fibronectin"],"prefix":"10.1016","volume":"67","author":[{"given":"Alexander","family":"Lubosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren","family":"Zoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3024-5138","authenticated-orcid":false,"given":"Franziska","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Exner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Steigenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Wabnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Schroeder-Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2649-9009","authenticated-orcid":false,"given":"Inaam A.","family":"Nakchbandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2025.101196_bib0001","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41417-021-00318-4","article-title":"Cancer-associated fibroblasts: overview, progress, challenges, and directions","volume":"28","author":"Ping","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.neo.2025.101196_bib0002","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1038\/s41388-019-0765-y","article-title":"Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment","volume":"38","author":"Bu","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2025.101196_bib0003","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-24-2860","article-title":"Pancreatic cancer-associated fibroblasts: where do we go from here?","volume":"84","author":"Carpenter","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101196_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072480","article-title":"Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody","volume":"8","author":"Hernandez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2025.101196_bib0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.advms.2015.04.006","article-title":"Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro","volume":"60","author":"Teichgraber","year":"2015","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.neo.2025.101196_bib0006","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2025.101196_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146987","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"Bhattacharjee","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2025.101196_bib0008","article-title":"Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Disease"},{"key":"10.1016\/j.neo.2025.101196_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-39553-z","article-title":"Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1 + TAMs","volume":"9","author":"Gok Yavuz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2025.101196_bib0010","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ccell.2021.06.017","article-title":"Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity","volume":"39","author":"Hutton","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2025.101196_bib0011","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143759","article-title":"Neutrophil dynamics in the tumor microenvironment","volume":"131","author":"McFarlane","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2025.101196_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52956-2","article-title":"Neutrophil activation causes tumor regression in Walker 256 tumor-bearing rats","volume":"9","author":"Kuwabara","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2025.101196_bib0013","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101196_bib0014","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neo.2025.101196_bib0015","doi-asserted-by":"crossref","unstructured":"Ricci, B., Tycksen, E., Celik, H., Belle, J.I., Fontana, F., Civitelli, R., and Faccio, R. (2020). Osterix-cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with pro-tumorigenic characteristics. Elife 9. 10.7554\/eLife.54659.","DOI":"10.7554\/eLife.54659"},{"key":"10.1016\/j.neo.2025.101196_bib0016","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1158\/0008-5472.CAN-16-3507","article-title":"A subpopulation of stromal cells controls cancer cell homing to the bone marrow","volume":"78","author":"Rossnagl","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101196_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094922","article-title":"Blood clot formation does not affect metastasis formation or tumor growth in a murine model of breast cancer","volume":"9","author":"Rossnagl","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2025.101196_bib0018","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1359\/jbmr.091011","article-title":"Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function","volume":"25","author":"Bentmann","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.neo.2025.101196_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101058","article-title":"Insights into the metastatic bone marrow niche gained from fibronectin and beta1 integrin transgenic mice","volume":"58","author":"Wirth","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.neo.2025.101196_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116150","article-title":"Cdc42 in osterix-expressing cells alters osteoblast behavior and myeloid lineage commitment","volume":"153","author":"Wirth","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.neo.2025.101196_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028181","article-title":"Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-beta","volume":"6","author":"Kawelke","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2025.101196_bib0022","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1593\/neo.13762","article-title":"Circulating fibronectin controls tumor growth","volume":"15","author":"von Au","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.neo.2025.101196_bib0023","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/00365520903490606","article-title":"Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C","volume":"45","author":"Hackl","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.neo.2025.101196_bib0024","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1006\/geno.1995.1187","article-title":"Positional cloning of the nude locus: genetic, physical, and transcription maps of the region and mutations in the mouse and rat","volume":"28","author":"Segre","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.neo.2025.101196_bib0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neo.2021.06.012","article-title":"Inhibition of fibronectin accumulation suppresses tumor growth","volume":"23","author":"Ghura","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.neo.2025.101196_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002562","article-title":"EDA-fibronectin originating from osteoblasts inhibits the immune response against cancer","volume":"14","author":"Rossnagl","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neo.2025.101196_bib0027","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12885-021-07875-9","article-title":"Fibronectin mediates activation of stromal fibroblasts by SPARC in endometrial cancer cells","volume":"21","author":"Yoshida","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neo.2025.101196_bib0028","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.kint.2016.12.006","article-title":"Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes","volume":"91","author":"Klemis","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.neo.2025.101196_bib0029","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41571-021-00499-9","article-title":"Novel approaches to target the microenvironment of bone metastasis","volume":"18","author":"Hofbauer","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.neo.2025.101196_bib0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ceb.2008.06.001","article-title":"The role of integrin binding sites in fibronectin matrix assembly in vivo","volume":"20","author":"Leiss","year":"2008","journal-title":"Current Opin. Cell Biol."},{"key":"10.1016\/j.neo.2025.101196_bib0031","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe9716","article-title":"Structural insights into integrin alpha(5)beta(1) opening by fibronectin ligand","volume":"7","author":"Schumacher","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neo.2025.101196_bib0032","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1471-2407-10-330","article-title":"The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion","volume":"10","author":"Kamarajan","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neo.2025.101196_bib0033","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jbmr.2916","article-title":"An O-glycosylation of fibronectin mediates hepatic osteodystrophy through alpha4beta1 integrin","volume":"32","author":"Sens","year":"2017","journal-title":"J. Bone Miner Res."},{"key":"10.1016\/j.neo.2025.101196_bib0034","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1600-065X.2002.18611.x","article-title":"Alpha4 integrins and the immune response","volume":"186","author":"Rose","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.neo.2025.101196_bib0035","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1038\/s41467-020-16596-9","article-title":"Durable and controlled depletion of neutrophils in mice","volume":"11","author":"Boivin","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101196_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094726","article-title":"Type I interferon-mediated regulation of antiviral capabilities of neutrophils","volume":"22","author":"Stegelmeier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2025.101196_bib0037","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1074\/jbc.M116.739987","article-title":"Fibronectins containing extradomain A or B enhance osteoblast differentiation via distinct integrins","volume":"292","author":"Sens","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2025.101196_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/cells11132074","article-title":"Fibronectin functions as a selective agonist for distinct toll-like receptors in triple-negative breast cancer","volume":"11","author":"Ambesi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neo.2025.101196_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122717","article-title":"Fibronectin and its receptors in hematopoiesis","volume":"9","author":"Wirth","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neo.2025.101196_bib0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/rb\/rbw041","article-title":"An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration","volume":"4","author":"Selders","year":"2017","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.neo.2025.101196_bib0041","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/2326-6066.CIR-19-0276","article-title":"Matrix-targeting immunotherapy controls tumor growth and spread by switching macrophage phenotype","volume":"8","author":"Deligne","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.neo.2025.101196_bib0042","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.12055","article-title":"Synergy of TLR4 agonist GSK1795091, an innate immune activator, with agonistic antibody against co-stimulatory immune checkpoint molecule OX40 in cancer immunotherapy","volume":"36","author":"Gao","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"609579","key":"10.1016\/j.neo.2025.101196_bib0043","article-title":"Toll-like receptor 4 activation in cancer progression and therapy","volume":"2011","author":"Oblak","year":"2011","journal-title":"Clin. Devel. Immunol."},{"key":"10.1016\/j.neo.2025.101196_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020142","article-title":"TLR agonists as vaccine adjuvants targeting cancer and infectious diseases","volume":"13","author":"Luchner","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neo.2025.101196_bib0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10456-019-09703-y","article-title":"Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis","volume":"23","author":"Ollauri-Ibanez","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.neo.2025.101196_bib0046","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1158\/0008-5472.CAN-17-3614","article-title":"TRPM2 mediates neutrophil killing of disseminated tumor cells","volume":"78","author":"Gershkovitz","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101196_bib0047","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/s41467-023-37515-8","article-title":"Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma","volume":"14","author":"Chung","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101196_bib0048","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00262-013-1476-9","article-title":"Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression","volume":"62","author":"Mishalian","year":"2013","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T07:08:15Z","timestamp":1753686495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"alternative-id":["S1476558625000764"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101196","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.05.14.653424","asserted-by":"object"}]},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immune response against cancer is modulated by stromal cell fibronectin","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101196"}}